We are live on ! Find out more
SBFMW icon

Sunshine Biopharma Warrant
SBFMW

4 hedge funds and large institutions have $2.94K invested in Sunshine Biopharma Warrant in 2026 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more funds holding

Funds holding: 3 → 4 (+1)

0.81% more ownership

Funds ownership: 2.12% → 2.93% (+0.81%)

Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Two Sigma Securities
Two Sigma Securities
New York
+$1.04K
2
Clear Street
Clear Street
New York
+$4
3
HRT Financial
HRT Financial
New York
+$1

Top Sellers

No sellers this quarter

SBFMW Hedge Fund Activity: Q3 2026 in Review

4 of the 8,173 institutional investors tracked by Wall St. Rank reported a position in Sunshine Biopharma Warrant (SBFMW) for Q3 2026, worth a combined $2.94K — up 14% from $2.57K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new SBFMW positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 0 trimmed.

The largest buyer was Two Sigma Securities, opening a new position worth an estimated $1.04K.

  • 4 institutional investors held Sunshine Biopharma Warrant (SBFMW) as of Q3 2026, up from 3 in Q2 2026.
  • Funds reported $2.94K of Sunshine Biopharma Warrant stock for Q3 2026, up 14% quarter-over-quarter.
  • 1 fund opened new Sunshine Biopharma Warrant positions in Q3 2026 and 0 closed out, a net change of +1 holder.
  • The largest Sunshine Biopharma Warrant buyer in Q3 2026 was Two Sigma Securities, an estimated $1.04K added.

Based on aggregated 13F filings for Q3 2026.